Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: 3 - The Real Truth

3 Healthcare Stocks Ready to Soar in 2024

Unlock the gates of wellness with these breakout healthcare stocks.

Barchart

The hospital ran out of her child's cancer drug. Now she's fighting to end shortages

Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.

WEKU

Chart of the Day: McKesson - Healthcare Star

The Chart of the Day belongs to the healthcare company McKesson (MCK) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Brian Tyler discusses McKesson's rollercoaster few years

McKesson took a drubbing for its role in shipping obscene quantities of opioids to the most addicted corners of America.

Fortune

Want to Get Richer in 2023? Try This Medical Stock

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….

StockNews.com

1 Warren Buffett Stock to Buy for 2023 if You Haven't Already

With the Fed’s continued interest-rate hikes expected to keep markets in perpetual turmoil, it would be opportune to load up on McKesson (MCK). The recession-resistant medical services market leader’s enduring competitive advantages and attractive valuation have also earned it a place in the portfolio of Warren Buffett-led Berkshire Hathaway (BRK).…

StockNews.com

2 Stocks Poised to Crush the Market Again in 2023

While the moderate inflation rate for November has boosted investor sentiment and may have paved the way for lower interest rate hikes from this month, Fed’s recent comments suggest that the target interest rate may be a bit further ahead. Hence shares of fundamentally strong businesses with robust demand, such…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks You Shouldn't Wait Any Longer to Buy

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks AbbVie (ABBV), Oracle Corporation (ORCL), and McKesson (MCK) could be opportune investments now. Continue reading….

StockNews.com

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

1 Growth Stock That's Worth Buying Into Before 2022 Ends

The Fed’s aggressive interest rate hikes this year have hurt growth stocks significantly. However, McKesson Corporation (MCK) has stood tall, becoming the second-best performing non-energy stock in the S&P 500 this year. With its growth expected to remain strong due to its strategic acquisition of Rx Savings Solutions (RxSS), it…

StockNews.com

1 Stable Stock Warren Buffett Owns and You Should Too

World-famous investor Warren Buffett picked up shares of healthcare services provider McKesson Corporation (MCK) this year. The company has raised its dividends for 16 consecutive years. With a recession expected next year, this healthcare services stock is expected to remain stable as demand for healthcare and related services usually remain…

StockNews.com

2 Stocks to Buy Now That Could Make You a Millionaire

With inflation showing signs of slowing down, markets have been buoyed by expectations of a softening monetary stance by the Fed. Hence, it could be opportune to invest in fundamentally strong stocks AT&T (T) and McKesson (MCK) with enough headroom to grow. Read on….

StockNews.com

Position Yourself for Major Growth in Q4 With These 2 Stocks

Despite the overall market uncertainty, investors could still find stocks well-poised for strong growth. To that end, McKesson (MCK) and Flowers Foods (FLO) could be solid additions to one’s portfolio this quarter, given their strong fundamentals and solid growth prospects. Read more….

StockNews.com

3 Stocks With Reasonable Upside Potential to Buy Now

The Fed’s determination to keep raising interest rates to bring inflation under control is increasing the odds of a recession. Although the stock market is expected to remain under pressure, Wall Street analysts expect a reasonable upside in McKesson Corporation (MCK), AmerisourceBergen Corporation (ABC), and TravelCenters of America (TA) in…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks With Growth Potential You Won't Want to Miss

The Federal Reserve’s single-minded battle against inflation is expected to keep the stock market volatile and the economy teetering on the brink of a recession. However, companies with resilient and profitable businesses might be able to endure the near-term challenges. Hence, we think it could be wise to invest in…

Benzinga

Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved by the U.S. Food and Drug Administration (FDA).

StockNews.com

2 Undervalued Stocks With Solid Growth Potential

As the elevated inflation and a potential hawkish Fed could keep the market under pressure, investing in McKesson (MCK) and ADT (ADT), which possess solid growth prospects and are currently trading at discounts to their peers, could be wise. Read on….

Chicago Sun-Times

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

WVa cities, counties reach $400M settlement with drug firms

West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors

StockNews.com

3 Winning Healthcare Stocks to Buy for the Rest of the Summer

Increased health awareness and the rapidly aging population are expected to drive the growth of healthcare companies. Healthcare stocks Cigna Corp. (CI), Humana (HUM), and McKesson Corp. (MCK) have bucked the market downtrend and are in momentum. Since the market is expected to remain under pressure in the near term,…

StockNews.com

Buffett Just Stocked up on These 3 Buy-Rated Stocks

Warren Buffett has been one of the most influential investors of all time. His careful methodology in picking stocks has made him a consistently successful investor. So, we think Warren Buffett stocks Occidental Petroleum (OXY), Celanese (CE), and McKesson (MCK), which are also rated Strong Buy or Buy in our…

Benzinga

Here's How Much You Would Have Made Owning McKesson Stock In The Last 20 Years

McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 5.66% on an annualized basis producing an average annual return of 12.71%. Currently, McKesson has a market capitalization of $46.56 billion.

Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today

McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 2.06% on an annualized basis producing an average annual return of 12.64%. Currently, McKesson has a market capitalization of $44.39 billion.

Benzinga

Where McKesson Stands With Analysts

Over the past 3 months, 5 analysts have published their opinion on McKesson (NYSE:MCK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

Upgrades

1 2 3 4 5

People

Dipanjan BanchurSince

722 stories

Pat Nabong

621 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.